Home » Topics » BioWorld Science

BioWorld Science
RSS

New lysine-specific demethylase 5B inhibitors identified at FibroGen

March 17, 2022

Shengke Pharmaceuticals discovers FLT inhibitors

March 17, 2022

NLRP4 mutations predict anti-PD-L1 treatment response in patients with NSCLC

March 17, 2022

LinKinVax and GTP Bioways collaborate on second-generation pan-coronavirus vaccine

March 16, 2022

Study reports insights into organ-specific aging

March 16, 2022

Satellos advances compounds to modulate muscle stem cell polarity for Duchenne muscular dystrophy

March 16, 2022

CD19/CD22 targeting bivalent CAR-T therapy show efficacy in leukemia models

March 16, 2022

Serum interleukin level changes reflect severe depression and PTSD

March 16, 2022

AbbVie and Scripps collaborate to develop direct-acting antivirals for COVID-19

March 16, 2022

Anti-IL1RAP CAN-10 antibody shows promise in the treatment of systemic sclerosis

March 16, 2022

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...